Retinal Diseases: all 817 studies
Page 7 of 9. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- Measuring Corneal Cells With Specular MicroscopyCompletedNCT01792154
- Microcurrent Stimulation to Treat Macular DegenerationCompletedNCT01790958
- Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal PhotographyStatus unknownNCT01790945
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01787669Phase 2
- Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in DenmarkCompletedNCT01785667
- Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of PrematurityCompletedNCT01780155
- Squalamine for the Treatment in Proliferative Diabetic RetinopathyCompletedNCT01769183Phase 2
- Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs LucentisCompletedNCT01760746
- Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDRStatus unknownNCT01759121Not applicable
- Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic RetinopathyCompletedNCT01758757Not applicable
- Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive RetinopathyStatus unknownNCT01753648Not applicable
- Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyCompletedNCT01746563Phase 1/2
- Uptake of Comprehensive Eye Examination TrialCompletedNCT01743781Not applicable
- Safety and Efficacy of Low-Fluence PRP for PDRTerminatedNCT01737957Not applicable
- Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for RetinopathyActive, not recruitingNCT01736059Phase 1
- Diabetic Retinopathy And the Myvisiontrack® (DRAMA) StudyCompletedNCT01728883
- Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic RetinopathyCompletedNCT01726075Phase 2/3
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT01724385Phase 4
- Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular ImagingTerminatedNCT01717937
- Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic RetinopathyCompletedNCT01694212Not applicable
- Topical Betaxolol for the Prevention of Retinopathy of PrematurityCompletedNCT01660620Phase 1
- Diabetes Visual Function Supplement StudyCompletedNCT01646047Not applicable
- The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong KongCompletedNCT01628289Not applicable
- Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS ChartCompletedNCT01622816
- Computer-based Screening for Diabetic RetinopathyCompletedNCT01614327
- Causes of Visual Loss in Retinal DiseaseStatus unknownNCT01613963
- Biomarkers of Diabetic Retinopathy ProgressionCompletedNCT01607190
- Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®TerminatedNCT01591902Phase 4
- A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic RetinopathyWithdrawnNCT01589718Phase 3
- A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)TerminatedNCT01589029Phase 1
- Intravitreal Aflibercept Injection for Radiation RetinopathyCompletedNCT01579760Phase 1
- Registry for Severe ROP and Treatment on Visual OutcomesCompletedNCT01559571
- Registration and Treatment of Pain During Eye Examination of PrematurityTerminatedNCT01552993Not applicable
- GW824575 First Time in HumanTerminatedNCT01551771Phase 1
- Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)CompletedNCT01546766
- Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General DiseasesCompletedNCT01546181
- Propranolol for Diabetic RetinopathyCompletedNCT01535495Phase 1
- An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationStatus unknownNCT01521065Phase 2
- Effect of Intravitreal Bone Marrow Stem Cells on Ischemic RetinopathyStatus unknownNCT01518842Not applicable
- Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular EdemaStatus unknownNCT01487629Phase 2
- Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)Status unknownNCT01486771Phase 4
- Vitrous Analysis in Proliferative Diabetic RetinopathyCompletedNCT01478763
- Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic RetinopathyCompletedNCT01478737Phase 2
- Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER)CompletedNCT01440660
- Annular Array Ultrasound in OphthalmologyCompletedNCT01415037
- Telemedicine Retinal Screening Utilizing a Mobile Medical UnitCompletedNCT01412905
- Spectral Domain Optical Coherence Tomography Imaging of the Eyes of NeonatesCompletedNCT01404247Phase 1
- Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaCompletedNCT01399515Phase 2
- Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathyStatus unknownNCT01389505Phase 2
- Nidek RS3000 Comparative StudyCompletedNCT01384487
- Retinal Laser by Multi-spot Photocoagulator and Driving EligibilityCompletedNCT01383772Not applicable
- Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic RetinopathyStatus unknownNCT01382498Phase 4
- Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic RetinopathyCompletedNCT01373476Phase 2
- The Comparative Effectiveness of Telemedicine to Detect Diabetic RetinopathyCompletedNCT01364129Not applicable
- Retinopathy of Prematurity:Summary of a DecadeCompletedNCT01363960
- Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human EyeStatus unknownNCT01348672
- A Scan Ultrasonography in the Evaluation of Retinopathy of PrematurityTerminatedNCT01335113
- High Dose Intravitreal Ranibizumab for Recalcitrant Radiation RetinopathyCompletedNCT01334879Phase 1
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes ControlCompletedNCT01323348Phase 3
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.Active, not recruitingNCT01320345Phase 3
- Macular Tractional Retinoschisis in Proliferative Diabetic RetinopathyStatus unknownNCT01312207
- Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic RetinopathyCompletedNCT01307072
- Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL LaserStatus unknownNCT01304225Phase 3
- Genetic Association of Diabetic Retinopathy-1Status unknownNCT01298245
- Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01298076Phase 2
- Diabetic Retinopathy Sulodexide StudyCompletedNCT01295775Phase 2
- Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.CompletedNCT01281098Phase 2
- Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic RetinopathyCompletedNCT01280929Phase 2
- Telemedicine Approaches to Evaluating Acute-phase ROPCompletedNCT01264276
- Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial TreatmentCompletedNCT01257815Phase 4
- Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal DetachmentsCompletedNCT01255293Not applicable
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)WithdrawnNCT01232777Phase 2
- Clinical Research on Retinal Neovascularization of Diabetic RetinopathyTerminatedNCT01229540Not applicable
- Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic RetinopathyCompletedNCT01228981
- Topical Application of Latanoprost in Diabetic RetinopathyCompletedNCT01225653Phase 4
- Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)Status unknownNCT01217762Phase 1
- Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic RetinopathyTerminatedNCT01213888Not applicable
- Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of PrematurityCompletedNCT01203436Phase 2/3
- Ranibizumab for Diabetic Traction Retinal DetachmentCompletedNCT01201161Phase 2
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and NephropathyStatus unknownNCT01175486Phase 4
- Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular EdemaTerminatedNCT01168258
- Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive ProceduresCompletedNCT01145599
- Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-BrazilCompletedNCT01131650
- Canthaxanthin Retinopathy: A Long-term ObservationCompletedNCT01128062
- Severe Proliferative Diabetic RetinopathyCompletedNCT01115257Not applicable
- Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic RetinopathyCompletedNCT01102946Phase 2
- Rituximab for Autoimmune RetinopathyCompletedNCT01086631Phase 1
- Safety and Efficacy of Propranolol in Newborns With Retinopathy of PrematurityCompletedNCT01079715Phase 2/3
- Study on Effective Mydriasis in Premature InfantsCompletedNCT01054027Not applicable
- Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic RetinopathyStatus unknownNCT01044875Not applicable
- Efficacy of PreOperative Bevacizumab for Diabetic Eye DiseaseCompletedNCT01041690Not applicable
- Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic RetinopathyCompletedNCT01025934Phase 4
- Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind PatientsCompletedNCT01024803Not applicable
- Cpap at Delivery Room for Preterm InfantsStatus unknownNCT01024361Phase 4
- Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence ParametersTerminatedNCT01023698Not applicable
- To Compare Visual Field Impairment in Conventional Double Frequency Nd: YAG Panretinal Photocoagulation With PASCAL Panretinal PhotocoagulationStatus unknownNCT01023113Not applicable
- Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)Status unknownNCT00993525Phase 1/2
- High Blood Pressure and Sleep Apnea in Diabetic Macular EdemaCompletedNCT00970723Not applicable
- Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy AloneStatus unknownNCT00931125Phase 2
- Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity ScreeningCompletedNCT00921544Phase 4